Chemotherapeutic effects of Apigenin in breast cancer: Preclinical evidence and molecular mechanisms; enhanced bioavailability by nanoparticles

This review highlights using nanotechnology in increasing the bioavailability of AP (Apigenin) to enhance its therapeutic efficacy in breast cancer treatment. Breast cancer is one of the most leading causes of cancer death in women both in developed and developing countries. According to several epi...

Descripción completa

Detalles Bibliográficos
Autores principales: Adel, Moein, Zahmatkeshan, Masoumeh, Akbarzadeh, Abolfazl, Rabiee, Navid, Ahmadi, Sepideh, Keyhanvar, Peyman, Rezayat, Seyed Mahdi, Seifalian, Alexander Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171451/
https://www.ncbi.nlm.nih.gov/pubmed/35686000
http://dx.doi.org/10.1016/j.btre.2022.e00730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171451/
https://www.ncbi.nlm.nih.gov/pubmed/35686000
http://dx.doi.org/10.1016/j.btre.2022.e00730

Ejemplares similares